RBC Capital initiated GE HealthCare Technologies with an Outperform rating and an $80 price target, citing strong R&D and growth potential.
RBC Capital initiated coverage of GE HealthCare Technologies Inc. (NASDAQ:GEHC) with an Outperform rating and an $80 price target. The firm highlighted the company’s attractive risk-reward profile, driven by stronger R&D spending and improved commercial execution since its 2023 separation from General Electric.
GEHC has built a solid order backlog expected to support faster growth later in 2026. The company operates in medical technology, pharmaceutical diagnostics, and digital solutions, with divisions focused on imaging, advanced visualization, patient care, and diagnostics.
Separately, GEHC announced plans to showcase cloud-enabled enterprise imaging technologies at the SIIM 2026 Annual Meeting, including AI-powered tools aimed at improving workflow efficiency for healthcare providers.